Pancreatic b-cell apoptosis is a key feature of diabetes mellitus and the mitochondrial pathway of apoptosis is a major mediator of b-cell death. We presently evaluated the role of the myeloid cell leukemia sequence 1 (Mcl-1), an antiapoptotic protein of the Bcl-2 family, in b-cells following exposure to well-defined b-cell death effectors, for example, pro-inflammatory cytokines, palmitate and chemical endoplasmic reticulum (ER) stressors. All cytotoxic stresses rapidly and preferentially decreased Mcl-1 protein expression as compared with the late effect observed on the other antiapoptotic proteins, Bcl-2 and Bcl-xL. This was due to ER stress-mediated inhibition of translation through eIF2a phosphorylation for palmitate and ER stressors and through the combined action of translation inhibition and JNK activation for cytokines. Knocking down Mcl-1 using small interference RNAs increased apoptosis and caspase-3 cleavage induced by cytokines, palmitate or thapsigargin, whereas Mcl-1 overexpression partly prevented Bax translocation to the mitochondria, cytochrome c release, caspase-3 cleavage and apoptosis induced by the b-cell death effectors. Altogether, our data suggest that Mcl-1 downregulation is a crucial event leading to b-cell apoptosis and provide new insights into the mechanisms linking ER stress and the mitochondrial intrinsic pathway of apoptosis. Mcl-1 is therefore an attractive target for the design of new strategies in the treatment of diabetes. Cell Death and Differentiation (2011) 18, 328-337; doi:10.1038/cdd.2010.105; published online 27 August 2010
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The mitochondrial intrinsic pathway of apoptosis controlled by the B-cell lymphoma 2 (Bcl-2) protein family 2 plays a major role in pancreatic b-cell death in both T1D and T2D. 3 The Bcl-2 protein family can be divided into three groups, the antiapoptotic proteins (Bcl-2, B-cell lymphoma-extra large (Bcl-XL), Bcl-w, myeloid cell leukemia sequence 1 (Mcl-1) and A1), the multi-domain pro-apoptotic proteins (Bcl2-associated X protein (Bax), Bcl-2 homologous antagonist/killer (Bak) and Bok) and the pro-apoptotic BH3-only proteins (including Bim, Bid, neuronal death protein 5 (DP5, also known as Harakiri (Hrk)), Puma, Bad and Noxa). Upon death stimulus, Bax translocates from the cytosol to the mitochondria and oligomerizes with Bak, resulting in mitochondrial outer membrane permeabilization (MOMP). This allows proteins located in the mitochondrial intermembrane space, such as cytochrome c, to be released in the cytosol, in which they associate with cytosolic proteins to activate downstream executioner caspases resulting in apoptosis. 4 The Bax/Bak activation is regulated by a delicate equilibrium between antiapoptotic Bcl-2 proteins and pro-apoptotic BH3-only proteins. Among the antiapoptotic proteins, overexpression of Bcl-2 and Bcl-XL have been shown to prevent b-cell apoptosis in a variety of models, [5] [6] [7] but they may hamper b-cell function. 7 The molecular role of Mcl-1 in b-cells remains to be characterized. Mcl-1 is structurally unique among the Bcl-2 family; it contains two PEST sequences (polypeptide sequences enriched in proline (P), glutamic acid (E), serine (S) and threonine (T)), which favor Mcl-1 degradation, thereby reducing its half-life. Mcl-1 activity is also regulated by phosphorylation by the c-Jun NH2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) pathways in response to a variety of cell stimuli. 8 This highly regulated state suggests that Mcl-1, rather than other Bcl-2 pro-survival proteins, is an early pivotal protein in the regulation of cell survival in response to extracellular signals.
Pro-inflammatory cytokines (interleukin 1 beta (IL-1b), tumor necrosis factor alpha (TNF-a) and interferon gamma (IFN-g)) and high concentrations of saturated free fatty acids (FFAs) such as palmitate are candidate mediators of beta cell apoptosis in T1D and T2D, respectively. 1 In this study, we investigated the effect of cytokines, FFAs and chemical endoplasmic reticulum (ER) stressors on Mcl-1 expression and, using both small interference RNA (siRNA) strategy and adenoviral-mediated Mcl-1 overexpression, explored the role of Mcl-1 in b-cell function and survival. The data obtained indicate that Mcl-1 is a key antiapoptotic protein in b-cells, which is rapidly degraded in response to pro-apoptotic stimuli, leading to increased Bax translocation to the mitochondria, cytochrome c release, cleavage of executioner caspase-3 and apoptosis in b-cells. These novel observations place Mcl-1 as key determinant of b-cell fate during severe stress.
Results

Pro-inflammatory cytokines and palmitate decrease
Mcl-1 expression in pancreatic b-cells. To evaluate the effect of pro-inflammatory cytokines on Mcl-1 expression, INS-1E cells were treated for 24 h with IL-1b, TNF-a and IFN-g, alone or in combination, as indicated ( Figure 1a ). Western blot analysis revealed the presence of a doublet of Mcl-1 isoforms around 40/42lkDa as described previously. 9 IL-1b alone decreased Mcl-1 expression by 30%. IFN-g and TNF-a had no effect individually, but induced a 40% decrease in Mcl-1 expression when combined. IFN-g also potentialized the effect of IL-1b, leading to a 60% reduction of Mcl-1 expression (for quantification see Supplementary data; Supplementary Figure S1a) . We have previously shown that cytokines induce ER stress in b-cells. 10 To test whether ER stress contributes to Mcl-1 decrease, INS-1E cells were exposed to the ER stressors thapsigargin, cyclopiazonic acid (CPA) and tunicamycin for 15 h, resulting in a similar 40-60% decrease in Mcl-1 expression (Figure 1b and Supplementary Figure S1b) . Salubrinal, a selective inhibitor of the cellular phosphatase complex that dephosphorylates the eukaryotic translation initiation factor 2 subunit alpha (eIF2a) 11 also significantly decreased Mcl-1 expression, although by 25% only (Figure 1b and Supplementary Figure S1b ). INS-1E cells were also incubated for 15 h in the presence of the FFA oleate and the saturated FFA palmitate, the latter a known b-cell death effector. 12, 13 Palmitate, but not oleate, decreased Mcl-1 expression by 50% (Figure 1c and Supplementary Figure S1b) . Similar to what we observed in INS-1E cells, Mcl-1 expression was decreased in primary rat islets treated for 48 h with TNF-a þ IFN-g or IL-1b þ IFN-g, or for 24 h with thapsigargin, CPA or palmitate (Figure 1d ). Time-course experiments of thapsigargin or IL-1b þ IFN-g treatment indicated that Mcl-1 protein expression is rapidly decreased (after 2 and 4 h of thapsigargin or IL-1b þ IFN-g treatment, respectively) as compared with the two other major antiapoptotic proteins, Bcl-2 and Bcl-XL, whose expressions were decreased only after 15 and 24 h of treatment with thapsigargin or IL-1b þ IFN-g, respectively (Figure 1e-f) . On the other hand, Mcl-1 mRNA expression was upregulated by cytokines, thapsigargin and palmitate, indicating that the Mcl-1 protein decrease is a post-transcriptional event (Figure 2a) .
Mcl-1 is constitutively targeted for degradation by the proteasome. 8 INS-1E cells treated with the proteosomal inhibitor MG-132 displayed increased basal Mcl-1 expression and the inhibitor prevented IL-1b þ IFN-g-, TNF-a þ IFN-g-, thapsigargin-and palmitate-induced Mcl-1 degradation (Figure 2b and Supplementary Figure S1c) , indicating that proteosomal degradation is involved in Mcl-1 downregulation. Cytokine-induced nitric oxide (NO) production is instrumental in cytokine-mediated ER stress and b-cell apoptosis, whereas palmitate and thapsigargin do not induce NO production in these cells. 10, 12 The NO synthase blocker NG-methyl-L-arginine (L-NMMA), which fully prevents cytokine-induced NO production in b-cells (data not shown; Cardozo et al. 10 ), had no effect on thapsigargin-mediated Mcl-1 decrease, whereas it completely prevented the (Figure 2c ). On the other hand, forskolin, an adenylate cyclase activator, which partially protects b-cells against cytokine-and palmitate-induced apoptosis, 14, 15 failed to prevent Mcl-1 degradation (Figure 2c ). INS-1E cells then were transfected with an siRNA targeting the PKR-like endoplasmic reticulum kinase (PERK), which is activated upon ER stress and phosphorylates the elongation factor eIF2a, resulting in decreased protein synthesis. 11 PERK knockdown using two different siRNAs decreased total PERK expression by 50% and nearly completely abolished thapsigargin-induced PERK phosphorylation (Figure 2d ). This resulted in a 50% decrease in basal and stress-induced eIF2a phosphorylation (Figure 2d Figure S1e) .
JNK has been reported to inactivate Mcl-1, 16 and cytokines induce a strong and rapid (1 h) JNK phosphorylation in INS-1E cells, 17, 18 leading to a peak of c-Jun phosphorylation between 6 and 8 h. We thus exposed INS-1E cells to IL-1b þ IFN-g for 8 h in the presence of the JNK inhibitor peptide (JNKi) 19 or the chemical JNK inhibitor SP600125. 18 Both inhibitors partially prevented the effect of cytokines on Mcl-1 expression, suggesting that JNK is involved in the cytokine-induced Mcl-1 downregulation (Figure 2f ). Western blot analysis of c-Jun phosphorylation confirmed the efficiency of the inhibitors in blocking JNK activity (Supplementary Figure S1f) . ER stress has been shown to induce a late JNK activation in bcells; 10 however, the JNKi peptide did not prevent the effects of a 15 h exposure to thapsigargin or palmitate on Mcl-1 downregulation. At this time point, JNK inhibition fully prevented the Mcl-1 downregulation induced by IL-1b alone or TNF-a þ IFN-g, and partially prevented the effect of IL-1b þ IFN-g (Figure 2g and Supplementary Figure S1c) . These data indicate that palmitate and thapsigargin downregulate Mcl-1 protein through ER stress-mediated inhibition of translation, whereas cytokines decrease Mcl-1 through the combined action of translation inhibition and JNK activation.
In other cell types, Mcl-1 stability has been shown to be modulated through phosphorylation by the ERK1,2 and the glycogen synthase kinase-3b (GSK-3b). 8 The role of Mcl-1 in b-cell apoptosis F Allagnat et al cells. 20, 21 The peak of IL-1b þ IFN-g-induced ERK activation occurs after 4-8 h of treatment, which is concomitant with Mcl-1 downregulation. However, blocking IL-1b þ IFN-g-induced ERK activity using PD98059 had no effect of Mcl-1 downregulation after 8 h exposure to IL-1b þ IFN-g (Supplementary Figure S2a ). Time-course experiments indicated that INS-1E cells have a high basal GSK-3a,b phosphorylation, suggesting a low GSK-3a,b activity since the phosphorylated form is inactive (Supplementary Figure S2b) . IL-1b þ IFN-g further stimulated GSK-3a,b phosphorylation after 8 h, and the levels of phospho (P)-and total GSK-3b were decreased at later time points (16 and 24 h). TNF-a þ IFN-g had no significant effect on P-GSK-3a,b and total GSK-3b (Supplementary Figure S2c ). We next analyzed Mcl-1 protein expression in the presence of two specific GSK-3b inhibitors (SB216763 and bromoindirubin-3 0 -oxime (BIO)) 22, 23 in INS-1E cells treated or not treated for 8 h with IL-1b þ IFN-g. As a control for the effects of the compounds on GSK-3 activity, we evaluated b-catenin protein expression; b-catenin is targeted for proteosomal degradation upon phosphorylation by GSK-3. 22 Both SB216763 and BIO increased beta-catenin expression in INS-1E cells, indicating that these compounds efficiently inhibit GSK-3 activity (Supplementary Figure S2d) . On the other hand, the two inhibitors had no effect on Mcl-1 expression, indicating that GSK-3- The endogenous Mcl-1 protein was also located in the mitochondrial fraction and absent from the cytosolic fraction. As previously described in other cell types, 2 Bak colocalized with the mitochondrial marker CoxIV, whereas Bax was located in the cytosol (Figure 5b ). Interestingly, Bcl-2 and Bcl-XL were present in both cytosolic and mitochondrial fractions, in line with previous reports that Bcl-2 and Bcl-XL have a broader Mcl-1 overexpression prevents Bax translocation to the mitochondria. Mcl-1 has been shown to modulate Bax/Bakmediated MOMP, release of cytochrome c and apoptosis. 24 We studied Bax and cytochrome c localization by immunostaining in INS-1E cells overexpressing Mcl-1 and exposed to IL-1b þ IFN-g. Upon apoptosis (determined by nucleus morphology using DNA labeling by Hoechst (HO)), INS-1E cells displayed a diffuse cytosolic cytochrome c staining, whereas it was discrete and typically mitochondrial in living cells, colocalizing with the mitochondrial marker apoptosisinducible factor (AIF) (Figure 7a ). The mitochondrial morphology, monitored using AIF (Figure 7a was not a transcriptional event, but was secondary to ER stress-mediated inhibition of translation for palmitate and ER stressors, and to the combined action of translation inhibition and JNK activation for cytokines. Altogether, these novel observations strongly suggest that Mcl-1 degradation may be a decisive step leading to b-cell apoptosis in T1D and T2D.
Mcl-1 is a very labile protein with a 30-90 min half-life and inhibition of de novo Mcl-1 synthesis results in rapid Mcl-1 downregulation. 8 In this study, we confirm our previous findings that palmitate 13, 26 and cytokines 10 induce the PERK-eIF2a pathway in b-cells, leading to decreased protein translation. 11 We presently show, using salubrinal, that phosphorylation of eIF2a is sufficient to significantly reduce Mcl-1 protein level. Knocking down PERK confirmed that eIF2a phosphorylation is instrumental in palmitate-and thapsigargin-induced Mcl-1 downregulation. This is in line with previous reports of eIF2a-dependent Mcl-1 downregulation in other cell types. 27, 28 The effect of cytokines is, however, more complex as blocking eIF2a phosphorylation only partly prevents cytokine-induced Mcl-1 downregulation. Mcl-1 stability in other cell types is influenced through phosphorylation of various residues by multiple kinases, including JNK, ERK and GSK-3b. 8 Cytokines induce JNK in b-cells 18,29 and phosphorylation of Mcl-1 by JNK facilitates Mcl-1 degradation in HEK293 cells. 16 We presently observed that JNK contributes to cytokine-mediated Mcl-1 downregulation. Cytokine-induced JNK phosphorylation is a rapid and transitory event (peak at 1 h), probably contributing to the early Mcl-1 degradation (4-8 h). The role of JNK, however, is partial and restricted to cytokines (blocking JNK did not prevent palmitate-or thapsigargin-induced Mcl-1 degradation), indicating that translation arrest is the main event leading to Mcl-1 downregulation. ERK-mediated phosphorylation has been proposed to stabilize Mcl-1 and we previously showed that IL-1b þ IFN-g induce ERK in b-cells. 20, 21 However, blocking ERK activity had no effect on Mcl-1 expression, suggesting that ERK activation is not a major player in cytokine-induced changes in Mcl-1 expression in b-cells. This is in accordance with previous studies showing that ERK plays a minor role in Mcl-1 regulation in other models. 16, 30 GSK-3 has also been shown to phosphorylate Mcl-1, thereby facilitating its degradation; 31 however, our present data suggest that INS-1E cells have low GSK-3b activity, and that the kinase is not involved in Mcl-1 regulation.
Altogether, our data show that palmitate and thapsigargin decrease Mcl-1 expression by ER stress-dependent inhibition Increasing evidence support the involvement of Bcl2 family members in b-cell apoptosis in response to pro-inflammatory cytokines, saturated FFA and ER stress. 3, [5] [6] [7] 13, 18, 32 Here, we show that cytokines, palmitate and thapsigargin, induce Bax translocation, cytochrome c release and caspase-3 cleavage, independently of changes in Bcl-2, Bcl-XL, Bax and Bak expression levels, but partly as a consequence of Mcl-1 downregulation (Figure 8 ). Our data are in agreement with previous studies showing that Mcl-1, in spite of its preferential mitochondrial localization, 33 is able to prevent Bax activation and translocation. 24 The fact that Mcl-1 is unlikely to interact directly with Bax 33 suggests that additional factors are involved in the inhibitory action of Mcl-1 on Bax translocation. Truncated Bid (tBid) is one of the factors contributing to Bax translocation to the mitochondria, 34 and has been shown to be involved in cytokine-induced b-cell apoptosis. 35 Mcl-1 has been proposed to act by sequestering tBid, thereby blocking Bax translocation and cytochrome c release. 36 Further studies remain to be performed to 37 suggesting that additional proteins involved in Bax translocation might be sequestered by Mcl-1. In line with this hypothesis, we recently showed that the pro-apoptotic BH3-only proteins DP5/Hrk and PUMA, which are rapidly overexpressed in response to ER stress and cytokines in b-cells, are involved in b-cell apoptosis. 18, 32 Taken together, these data suggest that, at least in the case of cytokines, proteins of the Bcl-2 family are regulated at several levels in b-cells; while Mcl-1 is degraded, BH3-only proteins (tBid, DP5, PUMA, etc.) are activated, thereby tipping the pro-/antiapoptotic balance toward apoptosis. Alternatively, other pro-apoptotic mechanisms involving additional Bcl-2 family members (Bim, NOXA, etc.) and/or other pathways (XIAP, FLIPs, etc.) may contribute to b-cell apoptosis.
Many reports suggest that ER stress plays a major role in palmitate-induced b-cell apoptosis. 12, 13, 26, 38 The present data support this hypothesis and provide new insights into the mechanism linking palmitate, ER stress and the intrinsic pathway of apoptosis through eIF2a phosphorylation and Mcl-1 degradation. On the other hand, the role of ER stress in cytokine-induced b-cell apoptosis remains controversial. 10, [38] [39] [40] We presently show that the cytokine effects on Mcl-1 require ER stress-dependent and -independent mechanisms (JNK activation), suggesting that cytokines may, depending on the severity and duration of exposure, induce apoptosis by ER stress-dependent and -independent mechanisms. This may account for the contradictory findings in this field. 10, [38] [39] [40] Altogether, our data point out Mcl-1 degradation, whether it is due to ER stress or JNK activation, as a novel and common mechanism for b-cell apoptosis triggered by potential death effectors involved in the onset of T1D and T2D (Figure 8) .
New strategies to prevent the development of diabetes require improving b-cell survival without impairing function, for example, GSIS. Bcl-XL overexpression improves b-cell survival, but impairs glucose oxidation and GSIS, 7 and the BH3-only protein BAD is also an important modulator of GSIS, 41 suggesting that some members of the Bcl-2 family have 'day' and 'night' jobs in b-cells, affecting both cell survival and function. 42 This is apparently not the case for Mcl-1 as neither Mcl-1 knockdown nor overexpression altered GSIS. These observations strongly suggest that the role of Mcl-1 in b-cells is restricted to the control of apoptosis and underline Mcl-1 as a promising target for the development of new strategies aiming to prevent b-cell apoptosis in diabetes.
Materials and Methods Materials. The following chemicals were purchased from Sigma-Aldrich NV/SA (Bornem, Belgium) and used as indicated: MG-132 (1 mM), tunicamycin (10 mg/ml), CPA (20 mM), thapsigargin (100 nM), salubrinal (75 mM), forskolin (10 mM), SP600125 (10 mM), SB216763 (5 mM), BIO (1 mM) and PD98059 (30 mM) were dissolved in DMSO. L-NMMA (1 mM) was dissolved in distilled water. Oleate and palmitate (sodium salt; Sigma-Aldrich) were dissolved in 90% ethanol, heated to 601C and diluted (final concentration 0.5 mM) in RPMI 1640 with 1% BSA and 1% fetal calf serum (cFFA medium). 13, 26 The peptides JNK inhibitor L-TAT-JNKi and control peptide L-TAT (a kind gift from C Bonny and M Mathieu; XigenPharma, Lausanne, Switzerland) were dissolved in culture medium and used at 10 mM as described previously. 19 The following cytokine concentrations were used: recombinant human IL-1b (gift from CW Reinolds, National Cancer Institute, Bethesda, MD, USA) at 10 U/ml in INS-1E cells and 50 U/ml in primary cells; recombinant rat IFN-g (R&D Systems, Abingdon, UK) at 100 U/ml (0.0072 mg/ml) in INS-1E cells and 500 U/ml (0.036 mg/ml) in primary cells; 10 and recombinant human TNF-a (R&D Systems) at 1000 U/ml in INS-1E cells and primary cells. The selected concentrations of ER stressors, FFA and cytokines are based on previous dose-response studies from our group. 10, 12, 26 Cell culture. The rat insulinoma cell line INS-1E (kindly provided by Prof. Claes Wollheim, CMU, University of Geneva, Geneva, Switzerland) was maintained in the complete RPMI 1640 medium as described previously. 10 Male Wistar rats (Charles River Laboratories, Brussels, Belgium) were housed and manipulated according to the guidelines of the Belgian Regulations for Animal Care; all experiments performed were approved by the local ethics committee. Rat islets were isolated by collagenase digestion followed by hand picking under a stereomicroscope. Islets were then dispersed and primary b-cells were purified by FACS using the auto-fluorescent properties of b-cells (FACSAria, BD Bioscience, San Jose, CA, USA) 10 The preparations used in this study contained 90.1 ± 3.8% b-cells (n ¼ 11). Dispersed islets or FACS-purified b-cells were pre-cultured in complete b-cell medium supplemented with 5% heatinactivated fetal bovine serum from 20 to 48 h for recovery. 13 Experiments were then conducted in the medium without serum. 10 Western blot analysis. Cells were washed once with cold PBS and directly lysed with Laemmli buffer. Lysates were then resolved by SDS-PAGE and transferred to a PVDF membrane. Immunoblot analyses were performed as described previously, 13, 18 using the following antibodies: polyclonal anti-rat Mcl-1 from Biovision (Gentaur, Brussels, Belgium); polyclonal anti-CHOP/GADD153, monoclonal anti-b-catenin (D-10) and polyclonal anti-Bax (P-19) from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA); polyclonal anti-P-GSK-3a,b, polyclonal anti-GSK-3b, polyclonal anti-P-ERK1,2, polyclonal anti-ERK1,2, polyclonal anti-P-PERK, polyclonal anti-PERK, polyclonal anti-P-eIF2a, polyclonal anti-CoxIV, RNA interference. The following siRNAs were used in this study:
Mcl PERK siRNA no. 2: rat Eif2ak3 Silencer Select pre-designed siRNA: GUAUCCAUAUGACAACGGU from Ambion. Allstars Negative Control siRNA (Qiagen, Venlo, the Netherlands), which has little effect on b-cell gene expression and no effect on cell viability. 20 siRNA transfection were conducted according to a protocol developed in our laboratory 13, 20 using DharmaFECT 1 (Thermo Fisher Scientific) with a final concentration of 30 nM siRNA. The efficiency of transfection was 490%. 13, 20 Cells were then cultured for a 48-h recovery period before being collected or treated as indicated.
Generation of recombinant adenoviruses and cell infection.
Ad-LUC was purchased from Vector Biolabs (Philadelphia, PA, USA). The adenovirus encoding rat Mcl-1 was generated by Vector Biolabs using rat myeloid cell leukemia 1 complete cds (cDNA clone MGC: 93459; IMAGE: 7121699; GenBank: BC078835) inserted in the pExpress-1 vector backbone (purchased at ImaGenes GmbH, Berlin, Germany). INS-1E cells and FACS-purified b-cells were infected as described previously. 43 Assessment of cell viability. The percentage of viable, apoptotic and necrotic cells was determined using the DNA-binding dyes propidium iodide (5 mg/ml) and HO (5 mg/ml; Sigma-Aldrich). 10 The cells were examined by inverted fluorescence microscopy (Axiovert 200, Carl Zeiss, Zaventem, Belgium). A minimum of 500 cells was counted in each experimental condition by two independent observers, one of them unaware of the sample identity. There was no difference in viability between non-treated cells (control (ctrl)), cells exposed to the ER stressors solvent DMSO (0.005-0.1%) or cells incubated in the FFA medium (data not shown); thus, the ctrl data showed in viability figures are mean±S.E.M. of the different controls used in the experiments. The necrosis levels were low throughout the experiments and were not significantly changed between different experimental conditions in INS-1E cells (1.32 ± 0.22%: mean necrosis levels in all conditions) and FACS-purified primary b-cells (2.03 ± 0.34%: mean necrosis levels in all conditions). Apoptosis was confirmed by caspase-3 cleavage (described above in 'Western blot analysis') and Bax translocation (see below in 'Immunofluorescence').
mRNA extraction and quantitative RT-PCR. Poly(A) þ mRNA was isolated from dispersed islet cells using the Dynabeads mRNA DIRECT kit (Invitrogen, Paisley, UK) and reverse transcribed as described previously. 10 Quantitative PCR was performed using the IQ SYBR Green Supermix (BIO-RAD, Nazareth Eke, Belgium) in an IQ5 instrument (BIO-RAD). Expression values were corrected for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Cytokines, FFAs or ER stressors treatments do not modify GAPDH expression in insulin-producing cells under the present experimental conditions. 10, 12, 26 The primers used in this study were: rat Mcl-1: Fw -5 0 -CCTCCAG CCACCAACTACAT-3 0 ; rev -5 0 -CCACTTTCTTTCTGCCGTGTTA-3 0 ; and rat GAPDH: Fw -5 0 -AGTTCAACGGCACAGTCAAG-3 0 ; rev -5 0 -TACTCAGCACCAG CATCACC-3 0 .
Subcellular fractionation. One million INS-1E cells plated in a six-well plate were infected using Ad-LUC or Ad-Mcl-1. After 48 h, cells were extracted using the PIERCE Mitochondria Isolation Kit for Cultured Cells (Thermo Fisher Scientific) according to the manufacturer's instructions.
Immunofluorescence. INS-1E cells grown on glass culture slides (BD Biosciences Europe, Erembodegem, Belgium) were fixed for 15 min in fresh 4% paraformaldehyde, rinsed in PBS and permeabilized for 5 min in PBS-Triton X-100 0.1%. Slides were then blocked using PBS-goat serum 5% and incubated overnight at 41C in the presence of polyclonal rabbit anti-Bax (1/1000; Santa Cruz Biotechnology Inc.), monoclonal mouse anti-cytochrome c or anti-ATP synthase b (1/2000; BD Biosciences). For the proliferation assay using BrdU, INS-1E cells were incubated for 6 h in a 100 mM BrdU solution before fixation. After PBS washing, DNA was denaturated by incubating cells in HCl 2N for 30 min. Acid solution was neutralized by washing twice in borate buffer 0.1 M. Slides were then blocked using PBS-goat serum 5% and incubated overnight at 41C in the presence of purified mouse anti-BrDU (1/500; BD Biosciences). Cells were then washed and further exposed for 1 h to appropriate Alexa Fluor 488-or 555-conjugated antibodies (1/1000; NV Invitrogen SA, Merelbeke, Belgium). After washing, cells were stained with HO, mounted and photographed using fluorescence microscopy (Axio Imager, Carl Zeiss). A minimum of 600 cells was counted in each experimental condition by two independent observers, one of them unaware of the sample identity.
Insulin secretion measurements. INS-1E cells were plated at a density of 150 000 cells per condition. At 48 h after infection or transfection, cells were incubated for 30 min in glucose-free INS-1E medium. Cells were washed in KRBH (Krebs-Ringer/bicarbonate-HEPES) buffer and pre-incubated for 30 min in glucose-free KRBH buffer (20 mM NaCl, 3.5 mM KCl, 0.5 mM NaH 2 PO 4 , 1.5 mM CaCl 2 , 5 mM NaHCO 3 , 10 mM HEPES and 0.1% BSA). Cells were then incubated for 30 min in KRBH supplemented with 1.67 mM glucose, 16.7 mM glucose or 16.7 mM glucose þ 10 mM forskolin. Insulin release was measured using the High Range Rat Insulin ELISA according to the manufacturer's instruction (Mercodia AB, Uppsalla, Sweden).
Statistical analyses. Data are presented as means ± S.E.M. Comparisons were performed by two-tailed paired Student's t-test or by ANOVA, followed by t-tests with Bonferroni correction for multiple comparison. A P-value p0.05 was considered statistically significant.
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